ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ARQT

Stock NameArcutis Biotherapeutics Inc
TickerARQT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03969K1088

Show aggregate ARQT holdings

News associated with ARQT

Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 3.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 29,697 shares of the company’s stock after purchasing an additional 917 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Arcutis Biotherapeutics were worth $464,000 at the […] - 2025-08-08 04:56:49
Arcutis Biotherapeutics (NASDAQ:ARQT) Coverage Initiated at The Goldman Sachs Group
The Goldman Sachs Group began coverage on shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) in a research report released on Friday, MarketBeat.com reports. The brokerage issued a neutral rating and a $18.00 price target on the stock. A number of other brokerages have also commented on ARQT. Needham & Company LLC reiterated a “buy” […] - 2025-07-28 02:05:01
Patrick Burnett Sells 23,000 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Patrick Burnett sold 23,000 shares of the company’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $15.05, for a total value of $346,150.00. Following the sale, the insider owned 115,468 shares of the company’s stock, valued at […] - 2025-07-16 05:29:11
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […] - 2025-07-10 05:48:58
SG Americas Securities LLC Has $509,000 Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
SG Americas Securities LLC lowered its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 32.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,566 shares of the company’s stock after selling 15,521 shares during the period. SG Americas Securities […] - 2025-06-23 04:29:10
Wealth Enhancement Advisory Services LLC Purchases Shares of 20,912 Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 20,912 shares of the company’s stock, valued at approximately $291,000. Other hedge funds and other institutional investors have also bought and sold shares of the […] - 2025-06-16 04:08:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 280,100 shares of the company’s stock […] - 2025-06-05 05:16:57
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Deutsche Bank AG
Deutsche Bank AG lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 51.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 387,536 shares of the company’s stock after selling 412,491 shares during the quarter. Deutsche Bank AG’s holdings […] - 2025-05-19 05:07:00
Northern Trust Corp Purchases 54,541 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Northern Trust Corp increased its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 5.8% during the fourth quarter, HoldingsChannel reports. The fund owned 991,056 shares of the company’s stock after buying an additional 54,541 shares during the quarter. Northern Trust Corp’s holdings in Arcutis Biotherapeutics were worth $13,805,000 at the end […] - 2025-05-16 04:22:56
Schonfeld Strategic Advisors LLC Sells 7,349 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Schonfeld Strategic Advisors LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 24.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,000 shares of the company’s stock after selling 7,349 shares during the quarter. Schonfeld Strategic Advisors […] - 2025-05-13 06:15:01
Price T Rowe Associates Inc. MD Reduces Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Price T Rowe Associates Inc. MD decreased its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 29.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,349 shares of the company’s stock after selling 17,799 shares during the […] - 2025-05-13 04:32:49
Voya Investment Management LLC Sells 2,472 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Voya Investment Management LLC trimmed its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,136 shares of the company’s stock after selling 2,472 shares during the period. Voya Investment […] - 2025-05-11 05:44:48
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Position Boosted by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC grew its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 62.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,231 shares of the company’s stock after buying an additional 5,488 shares during the quarter. […] - 2025-05-06 05:09:04
Wells Fargo & Company MN Has $731,000 Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Wells Fargo & Company MN increased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 46.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 52,455 shares of the company’s stock after purchasing an additional 16,682 shares during the quarter. Wells Fargo & Company MN’s holdings in Arcutis Biotherapeutics were […] - 2025-05-02 04:18:56
Geode Capital Management LLC Increases Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Geode Capital Management LLC boosted its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,472,730 shares of the company’s stock after buying an additional 2,592 shares during the quarter. Geode Capital Management LLC’s holdings in Arcutis Biotherapeutics were worth $34,453,000 as of […] - 2025-04-17 05:18:49
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Wellington Management Group LLP
Wellington Management Group LLP lowered its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 49,267 shares of the company’s stock after selling 3,882 shares during the quarter. Wellington Management Group LLP’s holdings in Arcutis Biotherapeutics […] - 2025-04-15 04:46:50
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by CIBC Private Wealth Group LLC
CIBC Private Wealth Group LLC reduced its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,782 shares of the company’s stock after selling 1,776 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Arcutis […] - 2025-04-08 06:03:20
Teacher Retirement System of Texas Boosts Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Teacher Retirement System of Texas grew its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 19.5% during the 4th quarter, HoldingsChannel reports. The fund owned 31,216 shares of the company’s stock after purchasing an additional 5,087 shares during the period. Teacher Retirement System of Texas’ holdings in Arcutis Biotherapeutics were worth $435,000 at […] - 2025-04-01 04:40:45
Intech Investment Management LLC Buys 5,168 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Intech Investment Management LLC boosted its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 13.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 42,258 shares of the company’s stock after acquiring an additional 5,168 shares during the period. Intech Investment Management LLC’s holdings in Arcutis Biotherapeutics were worth $589,000 […] - 2025-03-25 06:29:08
AlphaQuest LLC Decreases Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
AlphaQuest LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 83.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,142 shares of the company’s stock after selling 35,696 shares during the quarter. AlphaQuest LLC’s holdings in Arcutis Biotherapeutics were worth $99,000 as of its most recent filing […] - 2025-03-19 06:10:46
Bank of New York Mellon Corp Cuts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Bank of New York Mellon Corp decreased its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 305,007 shares of the company’s stock after selling 6,052 shares during the period. Bank […] - 2025-03-19 05:08:45
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says
Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Jefferies Financial Group from $16.00 to $19.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued research reports about the company. HC Wainwright reiterated a “buy” rating […] - 2025-03-12 04:56:51
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Mizuho Analyst Says
Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) had its target price lifted by stock analysts at Mizuho from $20.00 to $21.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 64.06% from the stock’s previous close. A number of […] - 2025-02-28 04:52:44

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ARQT holdings

DateNumber of ARQT Shares HeldBase Market Value of ARQT SharesLocal Market Value of ARQT SharesChange in ARQT Shares HeldChange in ARQT Base ValueCurrent Price per ARQT Share HeldPrevious Price per ARQT Share Held
2025-12-03 (Wednesday)84,967ARQT holding increased by 1684USD 2,545,611ARQT holding increased by 94592USD 2,545,6111,684USD 94,592 USD 29.96 USD 29.43
2025-12-02 (Tuesday)83,283ARQT holding increased by 2970USD 2,451,019ARQT holding increased by 11913USD 2,451,0192,970USD 11,913 USD 29.43 USD 30.37
2025-12-01 (Monday)80,313USD 2,439,106ARQT holding decreased by -22487USD 2,439,1060USD -22,487 USD 30.37 USD 30.65
2025-11-28 (Friday)80,313ARQT holding increased by 198USD 2,461,593ARQT holding decreased by -18767USD 2,461,593198USD -18,767 USD 30.65 USD 30.96
2025-11-27 (Thursday)80,115USD 2,480,360USD 2,480,3600USD 0 USD 30.96 USD 30.96
2025-11-26 (Wednesday)80,115ARQT holding increased by 594USD 2,480,360ARQT holding increased by 36680USD 2,480,360594USD 36,680 USD 30.96 USD 30.73
2025-11-25 (Tuesday)79,521ARQT holding increased by 990USD 2,443,680ARQT holding increased by 28066USD 2,443,680990USD 28,066 USD 30.73 USD 30.76
2025-11-24 (Monday)78,531ARQT holding increased by 198USD 2,415,614ARQT holding increased by 105574USD 2,415,614198USD 105,574 USD 30.76 USD 29.49
2025-11-21 (Friday)78,333USD 2,310,040ARQT holding increased by 169199USD 2,310,0400USD 169,199 USD 29.49 USD 27.33
2025-11-20 (Thursday)78,333ARQT holding decreased by -792USD 2,140,841ARQT holding decreased by -65955USD 2,140,841-792USD -65,955 USD 27.33 USD 27.89
2025-11-19 (Wednesday)79,125ARQT holding increased by 198USD 2,206,796ARQT holding increased by 53667USD 2,206,796198USD 53,667 USD 27.89 USD 27.28
2025-11-18 (Tuesday)78,927ARQT holding increased by 1188USD 2,153,129ARQT holding increased by 118699USD 2,153,1291,188USD 118,699 USD 27.28 USD 26.17
2025-11-17 (Monday)77,739ARQT holding increased by 396USD 2,034,430ARQT holding increased by 100855USD 2,034,430396USD 100,855 USD 26.17 USD 25
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARQT by Blackrock for IE00BYXG2H39

Show aggregate share trades of ARQT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03BUY1,68430.18029.280 29.370USD 49,459 15.59
2025-12-02BUY2,97030.48028.950 29.103USD 86,436 15.52
2025-11-28BUY19831.27030.390 30.478USD 6,035 15.38
2025-11-26BUY59431.10530.382 30.455USD 18,090 15.23
2025-11-26BUY59431.10530.382 30.455USD 18,090 15.23
2025-11-25BUY99030.99030.250 30.324USD 30,021 15.16
2025-11-24BUY19831.09529.640 29.785USD 5,898 15.08
2025-11-20SELL-79228.49027.220 27.347USD -21,659 14.95 Loss of -9,816 on sale
2025-11-19BUY19828.96027.000 27.196USD 5,385 14.89
2025-11-18BUY1,18827.84025.550 25.779USD 30,625 14.83
2025-11-17BUY39626.81024.820 25.019USD 9,908 14.77
2025-11-14BUY19825.20022.260 22.554USD 4,466 14.72
2025-11-12BUY19824.35023.240 23.351USD 4,623 14.64
2025-11-10BUY19724.86023.740 23.852USD 4,699 14.55
2025-11-06BUY19725.35023.770 23.928USD 4,714 14.44
2025-11-04BUY19824.56023.850 23.921USD 4,736 14.34
2025-10-30BUY99027.07924.770 25.001USD 24,751 14.17
2025-10-29BUY39625.29025.990 25.920USD 10,264 14.12
2025-10-22SELL-79219.81020.730 20.638USD -16,345 13.93 Loss of -5,311 on sale
2025-10-20BUY39620.88021.200 21.168USD 8,383 13.86
2025-10-17BUY98920.88021.085 21.064USD 20,833 13.82
2025-10-15BUY1,57621.63021.715 21.707USD 34,209 13.78
2025-10-03BUY1,38619.92021.300 21.162USD 29,331 13.70
2025-10-02BUY19821.25021.290 21.286USD 4,215 13.66
2025-09-30BUY39618.85019.360 19.309USD 7,646 13.60
2025-09-26BUY39617.57017.695 17.682USD 7,002 13.55
2025-09-25BUY39616.73017.349 17.287USD 6,846 13.53
2025-09-24SELL-2,95217.30017.950 17.885USD -52,797 13.51 Loss of -12,929 on sale
2025-09-18BUY20717.71017.880 17.863USD 3,698 13.48
2025-09-17BUY62417.14017.800 17.734USD 11,066 13.46
2025-08-20SELL-82815.79016.070 16.042USD -13,283 13.40 Loss of -2,190 on sale
2025-07-30BUY82414.58015.378 15.298USD 12,606 13.33
2025-07-17SELL-41215.48015.575 15.565USD -6,413 13.24 Loss of -959 on sale
2025-07-11SELL-1,65615.01015.300 15.271USD -25,289 13.18 Loss of -3,466 on sale
2025-07-07BUY62113.39013.805 13.764USD 8,547 13.15
2025-07-02BUY11,38513.76013.980 13.958USD 158,912 13.14
2025-06-20BUY1,99613.82014.300 14.252USD 28,447 13.14
2025-06-11BUY40213.73014.420 14.351USD 5,769 13.12
2025-06-10BUY40213.89014.410 14.358USD 5,772 13.11
2025-06-04SELL-20113.27013.470 13.450USD -2,703 13.09 Loss of -73 on sale
2025-04-23BUY20014.45015.020 14.963USD 2,993 12.77
2025-04-10SELL-1,60013.44013.870 13.827USD -22,123 12.73 Loss of -1,752 on sale
2025-04-08SELL-20013.29015.180 14.991USD -2,998 12.70 Loss of -457 on sale
2025-04-07SELL-20014.30015.000 14.930USD -2,986 12.69 Loss of -449 on sale
2025-04-04SELL-1,00014.73016.040 15.909USD -15,909 12.66 Loss of -3,247 on sale
2025-04-01BUY2,27314.98015.570 15.511USD 35,257 12.59
2025-03-31SELL-58815.64016.110 16.063USD -9,445 12.55 Loss of -2,066 on sale
2025-03-21BUY3,31017.01017.120 17.109USD 56,631 12.23
2025-03-14SELL-2,97614.62015.380 15.304USD -45,545 11.96 Loss of -9,957 on sale
2025-03-07SELL-37014.72014.860 14.846USD -5,493 11.73 Loss of -1,151 on sale
2025-03-04SELL-18613.40014.000 13.940USD -2,593 11.62 Loss of -432 on sale
2025-02-25BUY37212.20012.600 12.560USD 4,672 11.50
2025-02-19SELL-18512.99013.230 13.206USD -2,443 11.39 Loss of -335 on sale
2025-02-13BUY55512.31013.220 13.129USD 7,287 11.30
2025-02-12BUY18513.21013.880 13.813USD 2,555 11.26
2025-02-11BUY74011.40011.485 11.476USD 8,493 11.26
2024-12-30SELL-5,76614.20014.641 14.597USD -84,166 10.32 Loss of -24,648 on sale
2024-11-18SELL-3,0009.4309.460 9.457USD -28,371 9.00 Loss of -1,356 on sale
2024-11-08SELL-20010.82011.440 11.378USD -2,276 8.79 Loss of -518 on sale
2024-10-21SELL-2028.3108.810 8.760USD -1,770 0.00 Loss of -1,770 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARQT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19341,72635,090772,42344.2%
2025-09-18165,6611,522363,88745.5%
2025-09-17284,7250630,73645.1%
2025-09-16179,84422395,46645.5%
2025-09-15175,5520491,91735.7%
2025-09-12307,5250657,23546.8%
2025-09-11258,316280539,94347.8%
2025-09-10437,0271,316950,92546.0%
2025-09-09532,77001,150,71846.3%
2025-09-08452,8895,712986,45945.9%
2025-09-05361,617501,130,35932.0%
2025-09-04366,5611001,012,47736.2%
2025-09-03292,438175835,68435.0%
2025-09-02228,380100443,10451.5%
2025-08-29226,8061,350420,49453.9%
2025-08-28256,315377611,73641.9%
2025-08-27144,1010315,28145.7%
2025-08-26209,3330530,21039.5%
2025-08-25180,21750442,97240.7%
2025-08-22147,9960373,95839.6%
2025-08-2189,1170274,94032.4%
2025-08-20175,74954518,92033.9%
2025-08-1986,6020356,66024.3%
2025-08-18152,54334,957607,12125.1%
2025-08-15136,3350738,56718.5%
2025-08-14196,6290845,24223.3%
2025-08-13166,1444521,181,49014.1%
2025-08-12146,7970602,66424.4%
2025-08-11270,539384620,44143.6%
2025-08-08386,29825,0351,202,81532.1%
2025-08-071,109,37522,6311,675,04266.2%
2025-08-06341,0281,278574,75559.3%
2025-08-05223,064170693,79832.2%
2025-08-04217,70641446,61648.7%
2025-08-01401,6713,150744,55453.9%
2025-07-31177,568572398,66644.5%
2025-07-30265,582600669,79139.7%
2025-07-29251,3832,815615,84440.8%
2025-07-28302,3930690,49343.8%
2025-07-25450,5300755,42259.6%
2025-07-24186,949515400,24046.7%
2025-07-23169,5280376,35845.0%
2025-07-22284,8450536,87653.1%
2025-07-21278,122570433,72464.1%
2025-07-18282,6500669,37942.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy